These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11526857)

  • 21. DataWatch. Demystifying the drug spend.
    Bus Health; 2000; 18(7):46. PubMed ID: 11185085
    [No Abstract]   [Full Text] [Related]  

  • 22. Web survey. June results: 'prescription-drug spending'.
    Mod Healthc; 2002 Aug; 32(31):25. PubMed ID: 12224359
    [No Abstract]   [Full Text] [Related]  

  • 23. Medical-care spending--United States.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Aug; 43(32):581-6. PubMed ID: 8047056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Datawatch: Update on Rx drug spending.
    Bus Health; 2001 Sep; 19(8):48. PubMed ID: 11665673
    [No Abstract]   [Full Text] [Related]  

  • 25. Chronic patients spend up to five times more for health care than those without chronic conditions.
    Health Care Strateg Manage; 2001 Dec; 19(12):6-7. PubMed ID: 11799892
    [No Abstract]   [Full Text] [Related]  

  • 26. Canadian prescription drug costs surpass 18 billion dollars.
    Morgan S
    CMAJ; 2005 May; 172(10):1323-4. PubMed ID: 15883408
    [No Abstract]   [Full Text] [Related]  

  • 27. US health spending trends by age and gender: selected years 2002-10.
    Lassman D; Hartman M; Washington B; Andrews K; Catlin A
    Health Aff (Millwood); 2014 May; 33(5):815-22. PubMed ID: 24799579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months.
    Wettermark B; Hammar N; Fored CM; Leimanis A; Otterblad Olausson P; Bergman U; Persson I; Sundström A; Westerholm B; Rosén M
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):726-35. PubMed ID: 16897791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cost and availability of prescription drugs--what can we do in Massachusetts?
    Carpenter NW; Kedikoglou S
    Issue Brief (Mass Health Policy Forum); 1999 May; (4):1-41. PubMed ID: 12769091
    [No Abstract]   [Full Text] [Related]  

  • 30. National health spending in 2006: a year of change for prescription drugs.
    Catlin A; Cowan C; Hartman M; Heffler S;
    Health Aff (Millwood); 2008; 27(1):14-29. PubMed ID: 18180476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High drug costs seem to keep getting higher.
    Ackerman W
    J Ark Med Soc; 2005 Apr; 101(10):293. PubMed ID: 15839313
    [No Abstract]   [Full Text] [Related]  

  • 32. US spending on prescription drugs rose by 19% in 2000.
    Charatan F
    BMJ; 2001 May; 322(7296):1198. PubMed ID: 11358763
    [No Abstract]   [Full Text] [Related]  

  • 33. Factors accounting for the rise in health-care spending in the United States: the role of rising disease prevalence and treatment intensity.
    Thorpe KE
    Public Health; 2006 Nov; 120(11):1002-7. PubMed ID: 17030050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug spending hits 24.8 billion dollars.
    Kondro W
    CMAJ; 2006 Jul; 175(1):22. PubMed ID: 16818899
    [No Abstract]   [Full Text] [Related]  

  • 35. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia.
    Morgan SG; Agnew JD; Barer ML
    Health Policy; 2004 Jun; 68(3):299-307. PubMed ID: 15113641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Another theory about healthcare expenditures and inflation refuted by the facts.
    Bloom BS
    Am J Manag Care; 2001 Jul; 7(7):740-1. PubMed ID: 11464431
    [No Abstract]   [Full Text] [Related]  

  • 37. Projecting future drug expenditures--2007.
    Hoffman JM; Shah ND; Vermeulen LC; Schumock GT; Grim P; Hunkler RJ; Hontz KM
    Am J Health Syst Pharm; 2007 Feb; 64(3):298-314. PubMed ID: 17244880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aging and aggregate costs of medical care: conceptual and policy issues.
    Chernichovsky D; Markowitz S
    Health Econ; 2004 Jun; 13(6):543-62. PubMed ID: 15185385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of medicines in Canada.
    Han D; Wang EC
    Can J Clin Pharmacol; 2005; 12(1):e10-21. PubMed ID: 16055940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of population ageing on future Danish drug expenditure.
    Kildemoes HW; Christiansen T; Gyrd-Hansen D; Kristiansen IS; Andersen M
    Health Policy; 2006 Feb; 75(3):298-311. PubMed ID: 16399170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.